Questions of management of patients with hard-to-treat remitting multiple sclerosis
82 patients diagnosed with remitting multiple sclerosis, (MS) undergoing treatment with fingolimod were followed up for minimum 12 months at the Moscow Multiple Sclerosis Centre. The purpose of the follow-up was to evaluate the effects of fingolimod. 9 of 12 patients were subject to a comprehensive...
Shranjeno v:
| Principais autores: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Russo |
| Izdano: |
Remedium Group LLC
2015-12-01
|
| Serija: | Медицинский совет |
| Teme: | |
| Online dostop: | https://www.med-sovet.pro/jour/article/view/274 |
| Oznake: |
Brez oznak, prvi označite!
|